Adaptive Biotechnologies ADPT Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$49.64M+16.5% | -$59.46M+25.3% | -$79.6M+34.3% | -$121.24M+14.6% | -$141.89M+11.1% | ||
| $15.24M-5.5% | $16.13M-1.5% | $16.39M-1.1% | $16.57M-2.9% | $17.07M-2.7% | ||
| $51.26M-0.4% | $51.48M-0.2% | $51.6M-0.5% | $51.86M+0.8% | $51.46M-4.0% | ||
| -$29.09M+39.4% | -$48.04M+20.6% | -$60.53M+24.8% | -$80.47M+5.7% | -$85.34M+10.4% | ||
| $2.5M-15.6% | $2.96M+23.1% | $2.4M+2.8% | $2.34M-31.5% | $3.41M-6.9% | ||
| —— | —— | $68.32M+21.3% | $56.33M-4.3% | $58.86M-24.3% | ||
| $32.45M+6.7% | $30.4M+243% | $8.87M+22.7% | $7.23M+28.0% | $5.65M+2,244% | ||
| $26.93M+20.4% | $22.37M— | —— | —— | —— | ||
| -$30.95M+38.5% | -$50.36M+20.0% | -$62.94M+24.0% | -$82.81M+6.7% | -$88.76M+10.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Adaptive Biotechnologies generate?
- Adaptive Biotechnologies (ADPT) generated -$29.1M in operating cash flow over the trailing twelve months.
- What is Adaptive Biotechnologies's free cash flow?
- After $2.5M of capital expenditures, Adaptive Biotechnologies's free cash flow was -$31.0M over the trailing twelve months, up 65.1% year over year.
- Where does Adaptive Biotechnologies's cash flow data come from?
- Every line is extracted from Adaptive Biotechnologies's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
